Loading…
Based on limited metadata, this FDA Warning Letter issued to Pavlos Trifonidis S.A on July 30, 2019, addresses compliance issues with an unspecified product type classified as "Other." Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined, though the warning indicates the company failed to meet FDA regulatory requirements in their operations or product handling. The issuing office information is not available in the metadata provided, limiting visibility into which specific FDA division pursued this action.